Cornerstone Financial Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,048
Closed -$297K 141
2017
Q3
$297K Buy
2,048
+264
+15% +$36K 0.11% 100
2017
Q2
$234K Buy
+1,784
New +$219K 0.09% 110
2016
Q4
Sell
-2,377
Closed -$247K 182
2016
Q3
$247K Sell
2,377
-416
-15% -$45K 0.09% 131
2016
Q2
$275K Sell
2,793
-935
-25% -$96.7K 0.1% 136
2016
Q1
$377K Sell
3,728
-20,019
-84% -$2.06M 0.15% 112
2015
Q4
$2.83M Buy
+23,747
New +$2.75M 1.05% 23

Other funds holding CELG

Cornerstone Financial Partners's CELG Position: Q4 2017 in Review

Cornerstone Financial Partners sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 2,048 shares — an estimated $297K sold.

Cornerstone Financial Partners first reported a position in CELG in Q4 2015 and held it in 6 quarters. The position peaked at $2.83M in Q4 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Cornerstone Financial Partners reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Cornerstone Financial Partners sold 2,048 Celgene Corp shares in Q4 2017, an estimated $297K.
  • Cornerstone Financial Partners first reported a position in Celgene Corp in Q4 2015 and held it in 6 quarters.
  • Cornerstone Financial Partners's Celgene Corp position peaked at $2.83M in Q4 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Cornerstone Financial Partners's 13F filing for Q4 2017, filed 22 Jan 2018.